Brief: India's Bliss GVS Pharma Posts March-Qtr Consol Net Profit

Bliss GVS Pharma

20/05/2019 07:49

May 20 (Reuters) - Bliss GVS Pharma Ltd  BLIS.NS :
    * MARCH QUARTER CONSOL NET PROFIT 181.1 MILLION RUPEES
VERSUS LOSS
OF 143.2 MILLION RUPEES YEAR AGO
    * MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION
RUPEES
VERSUS 1.67 BILLION RUPEES YEAR AGO
    * RECOMMENDED DIVIDEND OF 1 RUPEE PER SHARE
    * APPROVED RE-APPOINTMENT OF S. N. KAMATH AS MD FOR PERIOD
OF
THREE YEARS

Source text: https://bit.ly/2HzPdZe
Further company coverage:  BLIS.NS 

 ((Reuters.Briefs@thomsonreuters.com;))